| |
|
|
|
ENDRA Life Sciences Inc.  
|
|
3.21 -0.08 (-0.02%) |
03-22 16:00 |
|
Open: |
3.28 |
Pre close: |
3.29 |
Target:
|
4.07
|
|
High: |
3.39 |
Low: |
2.96 |
Resistance:
|
3.49
4.07
|
|
Volume: |
346,088 |
Market Cap: |
24M |
Support:
|
2.30
1.56
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.92
 |
MACD |
MACD(12,26):
|
0.30 |
|
MA(20): |
2.19 |
Signal(12,26,9): |
0.16 |
|
MA(100): |
2.61  |
Stochastic Oscillator |
%K(14,3):
|
90.26 |
|
MA(250): |
2.57 |
%D(3): |
88.07 |
|
Average Volume(K) |
3-Month: |
31270
|
52-Week |
High:
|
5.75 |
|
10-Days: |
120951 |
Low: |
1.44 |
|
RSI |
RSI(14):
|
75.60 |
Change(%): |
11.5 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-170.0 |
Shares Out. (M) |
7.42 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-146.8 |
Shares Float (M) |
7.18 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
6.10 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
17.90 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
2.830 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.13 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-7.18 |
P/S |
0.00 |
|
Operating Margin |
-69296.92 |
Levered Free Cash Flow
(M) |
-3.24 |
P/CF |
-3.32 |
|
|
|
|
|
|
